186 related articles for article (PubMed ID: 26898400)
1. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.
Liu B; Xiang Y; Zhang HS
Mol Med Rep; 2015 Jul; 12(1):105-10. PubMed ID: 25738504
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
[TBL] [Abstract][Full Text] [Related]
6. Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(3):e0120794. PubMed ID: 25790297
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of miR-122 level in the plasma of chronically HCV infected patients].
Gholami M; Ravanshad M; Alavian SM; Baesi K; Moallemi S
Mol Biol (Mosk); 2016; 50(2):279-83. PubMed ID: 27239848
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
[TBL] [Abstract][Full Text] [Related]
10. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients.
Abdel-Al A; El-Ahwany E; Zoheiry M; Hassan M; Ouf A; Abu-Taleb H; Abdel Rahim A; El-Talkawy MD; Zada S
Virus Res; 2018 Jul; 253():135-139. PubMed ID: 29932949
[TBL] [Abstract][Full Text] [Related]
11. Absolute quantification of serum microRNA-122 and its correlation with liver inflammation grade and serum alanine aminotransferase in chronic hepatitis C patients.
Wang JH; Jiang D; Rao HY; Zhao JM; Wang Y; Wei L
Int J Infect Dis; 2015 Jan; 30():52-6. PubMed ID: 25461662
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
[TBL] [Abstract][Full Text] [Related]
13. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.
Lendvai G; Jármay K; Karácsony G; Halász T; Kovalszky I; Baghy K; Wittmann T; Schaff Z; Kiss A
World J Gastroenterol; 2014 Nov; 20(41):15343-50. PubMed ID: 25386083
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.
Oliveira KG; Malta FM; Nastri AC; Widman A; Faria PL; Santana RA; Alves VA; Carrilho FJ; Pinho JR
Med Microbiol Immunol; 2016 Apr; 205(2):111-7. PubMed ID: 26272127
[TBL] [Abstract][Full Text] [Related]
15. Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122.
van der Meer AJ; Farid WR; Sonneveld MJ; de Ruiter PE; Boonstra A; van Vuuren AJ; Verheij J; Hansen BE; de Knegt RJ; van der Laan LJ; Janssen HL
J Viral Hepat; 2013 Mar; 20(3):158-66. PubMed ID: 23383654
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
Bihrer V; Waidmann O; Friedrich-Rust M; Forestier N; Susser S; Haupenthal J; Welker M; Shi Y; Peveling-Oberhag J; Polta A; von Wagner M; Radeke HH; Sarrazin C; Trojan J; Zeuzem S; Kronenberger B; Piiper A
PLoS One; 2011; 6(10):e26971. PubMed ID: 22066022
[TBL] [Abstract][Full Text] [Related]
17. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
[TBL] [Abstract][Full Text] [Related]
18. Differences in serum microRNA profiles in hepatitis B and C virus infection.
Akamatsu S; Hayes CN; Tsuge M; Miki D; Akiyama R; Abe H; Ochi H; Hiraga N; Imamura M; Takahashi S; Aikata H; Kawaoka T; Kawakami Y; Ohishi W; Chayama K
J Infect; 2015 Mar; 70(3):273-87. PubMed ID: 25452043
[TBL] [Abstract][Full Text] [Related]
19. Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C.
Boštjančič E; Bandelj E; Luzar B; Poljak M; Glavač D
J Viral Hepat; 2015 Feb; 22(2):146-57. PubMed ID: 25065618
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.
Cermelli S; Ruggieri A; Marrero JA; Ioannou GN; Beretta L
PLoS One; 2011; 6(8):e23937. PubMed ID: 21886843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
